IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)
MPS IVA
University of California, San Franciscoprotein_peptidePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the MPS IVA cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Bmn 110 BioMarin Pharmaceutical | Phase 3 | BB |
Losartan Hospital de Clinicas de Porto Alegre | Phase 2 | CCC |
CHONDROITIN SULFATASE BioMarin Pharmaceutical | D | |
Bmn 110 BioMarin Pharmaceutical | Phase 3 | NR |
Same molecule, other indications
IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →